BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics

Agilent Technologies Inc. (NYSE: A) announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nuclei...

January 13, 2023 | News

Juniper Biologics Partners With Caris Life Sciences® for Molecular Profiling Distribution in South East Asia

The company's suite of market-leading molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physi...

January 12, 2023 | News

HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)

This double-blind, randomized, placebo-controlled, multicentre Phase 2b study will evaluate the effect of HTD1801, 1250 mg twice daily (BID), compared to p...

January 11, 2023 | News

Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023

Rade Drmanac, PhD, Chief Scientific Officer, announced "free three-month trial" program and "reagent rental leasing" program, giving customers the opportun...

January 11, 2023 | News

Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration

“This second collaboration with Astellas demonstrates the power of our antibody discovery capabilities. The depth and breadth of our Library of Libra...

January 10, 2023 | News

Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong

Luye Pharma has signed an agreement with Abacus Medicine Pharma Services (AMPS), an international healthcare and pharmaceutical services company, the terms...

January 10, 2023 | News

Agilent Announces Expansion of Portfolio With Acquisition of Avida Biomed

Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent T...

January 06, 2023 | News

Novogene Announces Deployment of Illumina NovaSeq™ X Plus and PacBio REVIO Sequencing Systems

Novogene is a trusted genomics partner to scientists worldwide and provides access to the latest genomics tools to the scientific community. The acquisitio...

January 06, 2023 | News

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program Duality to receive upfr...

January 05, 2023 | News

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

WuXi Biologics will provide an exclusive license to GSK for one preclinical bi-specific T cell engaging (TCE) antibody and the option of three additional...

January 05, 2023 | News

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program

Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug co...

January 04, 2023 | News